Market Research Logo

Muscle Relaxants Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

Muscle Relaxants Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024
The report on global muscle relaxants drugs market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global muscle relaxants drugs market to grow with a CAGR of 6.2% over the forecast period of 2018-2024. The study on muscle relaxants drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.
Increasing stress and tension levels among people due to work pressure, improper sleep, rising accidents and advance drug delivery technologies are some of the factors fueling the growth of muscle relaxants drug market. The online shopping of muscle relaxants are helping to increase the demand for muscle relaxant drugs. In addition, adoption of facial relaxants for anti-aging treatment is boosting the market growth. However, side effects caused by the muscle relaxants drugs hinders the market growth. Use of muscle relaxant drugs in different applications and rising usage in cosmetic industry can create a demand for muscle relaxant market in near future.
Geographically, North held the largest market share in 2017. The factors such as increase awareness about muscle relaxant drugs, adoption of online shopping for drugs are the factors driving growth in this region. Asia Pacific is expected to be the fastest growing CAGR among other regions owing to huge population base, rising stress/ tension level and improving healthcare infrastructures in this region.

Recent developments:-
Beximco Pharmaceuticals launched methocarbamol(500 mg and 700 mg) product for US market
In April 2018, Beximco Pharmaceuticals launched its third product Methocarbamol (500mg and 700mg) to the US market. A subsidiary of Beximco Group, it is the largest private business group in Bangladesh. The foundation of this Group was laid by two brothers – ASF Rahman and Salman F Rahman. Beximco Pharmaceuticals is the largest exporter of pharmaceuticals in Bangladesh. It manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients (API) and intravenous (IV) fluids. The latest product that Beximco Pharmaceuticals has decided to export to US is Methocarbamol, is generic equivalent to muscle relaxant drug Robaxin from Auxilium Pharmaceuticals.
Dr Reddy's launched anti-depressant, muscle relaxant tablets in US
In September 2017, Dr Reddy's Laboratories Limited launched anti depressant, Bupropion Hydrochloride Extended Release Tablets, 150 mg and 300 mg, as well as muscle relaxant drug Metaxalone in the US market. The anti-depressant drug is a generic equivalent version of Wellbutrin XL, a trademark of GlaxoSmithKline LLC. However, the generic version of Welbutrin SR (100 mg, 150 mg and 200 mg) is being sold by Dr Reddy's since September 2016. Metaxalone, which is used for the treatment of skeletal muscle conditions such as pain and injury, is a generic equivalent version of the Skelaxin brand of King Pharmaceuticals Research and Development, Inc.
Beximco's muscle relaxant drug got approval for US market
In July 2017,Beximco Pharma's muscle relaxant drug Methocarbamol has been cleared for the United States. The Bangladesh drug maker said in a statement on Monday that it received approval from the US Food and Drug Administration or FDA. This is the fourth product approval for Beximco in the US market and it expects to launch the product during last quarter of 2017, according to the statement. The company said there were four active generic players for Methocarbamol in the USA -- Camber, Qualitest, West-Ward and Solco.

I firmly believe this approval and our growing pipeline for US will largely help us build our presence in the world’s largest pharma market in the coming years,” said Beximco Pharma’s Managing Director Nazmul Hassan. In 2015, Beximco Pharma became the first Bangladeshi drug maker to be audited and approved by the FDA. It currently has a global footprint in more than 50 countries.
The report on muscle relaxants drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global muscle relaxants drugs market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global muscle relaxants drugs market over the period of 2016 to 2024. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global muscle relaxants drugs market is segmented on the basis of drugs type and distribution channel.

Global Muscle Relaxants Drugs Market by Drugs Type
Facial Muscle Relaxant Market
Skeletal Muscle Relaxant Market
Neuromuscular Relaxant Market
Global Muscle Relaxants Drugs Market by Distribution Channel
Drug Stores
Hospitals
Clinics
Online Stores

Company Profiles
Abbott Laboratories
Mallinckrodt plc.
Medtronic Neuromodulation (Medtronic Inc.)
Vertical Pharmaceuticals LLC
Johnson & Johnson
Par Sterile Products, LLC.
Endo Pharmaceuticals, Inc.
SteriMax Inc.
Upsher Smith Laboratories, Inc.
Orient Pharma Co., Ltd.

How this report delivers?
1. Comprehensive analysis of global as well as regional markets of muscle relaxants drugs market .
2. Complete coverage of all the segments in muscle relaxants drugs market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in global muscle relaxants drugs market . The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


The report on muscle relaxants drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global muscle relaxants drugs market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Muscle Relaxants Drugs Market Highlights
2.2. Muscle Relaxants Drugs Market Projection
2.3. Muscle Relaxants Drugs Market Regional Highlights
3. Global Muscle Relaxants Drugs Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Drugs Type
3.4.2. IGR-Growth Matrix Analysis by Distribution Channel
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value chain Muscle Relaxants Drugs Market
3.6. Import-Export data matrix
4. Muscle Relaxants Drugs Market Macro Indicator Analysis
5. Global Muscle Relaxants Drugs Market by Drugs Type
5.1. Facial Muscle Relaxant Market
5.2. Skeletal Muscle Relaxant Market
5.3. Neuromuscular Relaxant Market
6. Global Muscle Relaxants Drugs Market by Distribution Channel
6.1. Drug Stores
6.2. Hospitals
6.3. Clinics
6.4. Online Stores
7. Global Muscle Relaxants Drugs Market by Region 2018-2024
7.1. North America
7.1.1. North America Muscle Relaxants Drugs Market by Drugs Type
7.1.2. North America Muscle Relaxants Drugs Market by Distribution Channel
7.1.3. North America Muscle Relaxants Drugs Market by Country
7.2. Europe
7.2.1. Europe Muscle Relaxants Drugs Market by Drugs Type
7.2.2. Europe Muscle Relaxants Drugs Market by Distribution Channel
7.2.3. Europe Muscle Relaxants Drugs Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Muscle Relaxants Drugs Market by Drugs Type
7.3.2. Asia-Pacific Muscle Relaxants Drugs Market by Distribution Channel
7.3.3. Asia-Pacific Muscle Relaxants Drugs Market by Country
7.4. RoW
7.4.1. RoW Muscle Relaxants Drugs Market by Drugs Type
7.4.2. RoW Muscle Relaxants Drugs Market by Distribution Channel
7.4.3. RoW Muscle Relaxants Drugs Market by Sub-region
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Muscle Relaxants Drugs Market
8.2. Companies Profiles
8.2.1. Abbott Laboratories
8.2.1.1. Overview
8.2.1.2. Company Snapshot
8.2.1.3. Financial Snapshot
8.2.1.4. Product portfolio
8.2.1.5. Recent developments
8.2.2. Mallinckrodt Plc.
8.2.2.1. Overview
8.2.2.2. Company Snapshot
8.2.2.3. Financial Snapshot
8.2.2.4. Product portfolio
8.2.2.5. Recent developments
8.2.3. Medtronic Neuromodulation (medtronic Inc.)
8.2.3.1. Overview
8.2.3.2. Company Snapshot
8.2.3.3. Financial Snapshot
8.2.3.4. Product portfolio
8.2.3.5. Recent developments
8.2.4. Vertical Pharmaceuticals Llc
8.2.4.1. Overview
8.2.4.2. Company Snapshot
8.2.4.3. Financial Snapshot
8.2.4.4. Product portfolio
8.2.4.5. Recent developments
8.2.5. Johnson & Johnson
8.2.5.1. Overview
8.2.5.2. Company Snapshot
8.2.5.3. Financial Snapshot
8.2.5.4. Product portfolio
8.2.5.5. Recent developments
8.2.6. Par Sterile Products, Llc.
8.2.6.1. Overview
8.2.6.2. Company Snapshot
8.2.6.3. Financial Snapshot
8.2.6.4. Product portfolio
8.2.6.5. Recent developments
8.2.7. Endo Pharmaceuticals, Inc.
8.2.7.1. Overview
8.2.7.2. Company Snapshot
8.2.7.3. Financial Snapshot
8.2.7.4. Product portfolio
8.2.7.5. Recent developments
8.2.8. Sterimax Inc.
8.2.8.1. Overview
8.2.8.2. Company Snapshot
8.2.8.3. Financial Snapshot
8.2.8.4. Product portfolio
8.2.8.5. Recent developments
8.2.9. Upsher Smith Laboratories, Inc.
8.2.9.1. Overview
8.2.9.2. Company Snapshot
8.2.9.3. Financial Snapshot
8.2.9.4. Product portfolio
8.2.9.5. Recent developments
8.2.10. Orient Pharma Co., Ltd.
8.2.10.1. Overview
8.2.10.2. Company Snapshot
8.2.10.3. Financial Snapshot
8.2.10.4. Product portfolio
8.2.10.5. Recent developments
9. Appendix
9.1. Primary research findings and questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report